-
Something wrong with this record ?
The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?
BS Andresen, P Bross, S Udvari, J Kirk, G Gray, S Kmoch, N Chamoles, I Knudsen, V Winter, B Wilcken, I Yokota, K Hart, S Packman, JP Harpey, JM Saudubray, DE Hale, L Bolund, S Kolvraa, N Gregersen
Language English Country England, Great Britain
Grant support
IZ3204
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
PubMed
9158144
Knihovny.cz E-resources
- MeSH
- Acyl-CoA Dehydrogenase MeSH
- Acyl-CoA Dehydrogenases * genetics metabolism deficiency MeSH
- Enzyme Activation MeSH
- Alleles MeSH
- Chaperonin 60 genetics metabolism MeSH
- Chaperonin 10 genetics metabolism MeSH
- Child MeSH
- Escherichia coli genetics MeSH
- Exons MeSH
- Phenotype MeSH
- Heterozygote * MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Mutation * MeSH
- Infant, Newborn MeSH
- Polymerase Chain Reaction MeSH
- Child, Preschool MeSH
- Recombinant Proteins genetics metabolism MeSH
- Restriction Mapping MeSH
- Pedigree MeSH
- Sequence Analysis, DNA MeSH
- Sequence Deletion MeSH
- Temperature MeSH
- Blotting, Western MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Female MeSH
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most commonly recognized defect of mitochondrial beta-oxidation. It is potentially fatal, but shows a wide clinical spectrum. The aim of the present study was to investigate whether any correlation exists between MCAD genotype and disease phenotype. We determined the prevalence of the 14 known and seven previously unknown non-G985 mutations in 52 families with MCAD deficiency not caused by homozygosity for the prevalent G985 mutation. This showed that none of the non-G985 mutations are prevalent, and led to the identification of both disease-causing mutations in 14 families in whom both mutations had not previously been reported. We then evaluated the severity of the mutations identified in these 14 families. Using expression of mutant MCAD in Escherichia coli with or without co-overexpression of the molecular chaperonins GroESL we showed that five of the missense mutations affect the folding and/or stability of the protein, and that the residual enzyme activity of some of them could be modulated to a different extent depending on the amounts of available chaperonins. Thus, some of the missense mutations may result in relatively high levels of residual enzyme activity, whereas the mutations leading to premature stop codons will result in no residual enzyme activity. By correlating the observed types of mutations identified to the clinical/biochemical data in the 14 patients in whom we identified both disease-causing mutations, we show that a genotype/phenotype correlation in MCAD deficiency is not straightforward. Different mutations may contribute with different susceptibilities for disease precipitation, when the patient is subjected to metabolic stress, but other genetic and environmental factors may play an equally important role.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14043432
- 003
- CZ-PrNML
- 005
- 20140313155208.0
- 007
- ta
- 008
- 140124s1997 enk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)9158144
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Andresen, B. S. $u Center for Medical Molecular Biology, Aarhus University Hospital and Faculty of Health Science, Denmark. brage@biobase.dk $7 gn_A_00006548
- 245 14
- $a The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? / $c BS Andresen, P Bross, S Udvari, J Kirk, G Gray, S Kmoch, N Chamoles, I Knudsen, V Winter, B Wilcken, I Yokota, K Hart, S Packman, JP Harpey, JM Saudubray, DE Hale, L Bolund, S Kolvraa, N Gregersen
- 504 __
- $a Literatura
- 520 9_
- $a Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most commonly recognized defect of mitochondrial beta-oxidation. It is potentially fatal, but shows a wide clinical spectrum. The aim of the present study was to investigate whether any correlation exists between MCAD genotype and disease phenotype. We determined the prevalence of the 14 known and seven previously unknown non-G985 mutations in 52 families with MCAD deficiency not caused by homozygosity for the prevalent G985 mutation. This showed that none of the non-G985 mutations are prevalent, and led to the identification of both disease-causing mutations in 14 families in whom both mutations had not previously been reported. We then evaluated the severity of the mutations identified in these 14 families. Using expression of mutant MCAD in Escherichia coli with or without co-overexpression of the molecular chaperonins GroESL we showed that five of the missense mutations affect the folding and/or stability of the protein, and that the residual enzyme activity of some of them could be modulated to a different extent depending on the amounts of available chaperonins. Thus, some of the missense mutations may result in relatively high levels of residual enzyme activity, whereas the mutations leading to premature stop codons will result in no residual enzyme activity. By correlating the observed types of mutations identified to the clinical/biochemical data in the 14 patients in whom we identified both disease-causing mutations, we show that a genotype/phenotype correlation in MCAD deficiency is not straightforward. Different mutations may contribute with different susceptibilities for disease precipitation, when the patient is subjected to metabolic stress, but other genetic and environmental factors may play an equally important role.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a acyl-CoA-dehydrogenasa $7 D042964
- 650 12
- $a acyl-CoA-dehydrogenasy $x genetika $x metabolismus $x nedostatek $7 D044944
- 650 02
- $a mladiství $7 D000293
- 650 02
- $a alely $7 D000483
- 650 02
- $a western blotting $7 D015153
- 650 02
- $a chaperonin 10 $x genetika $x metabolismus $7 D018835
- 650 02
- $a chaperon hsp60 $x genetika $x metabolismus $7 D018834
- 650 02
- $a dítě $7 D002648
- 650 02
- $a předškolní dítě $7 D002675
- 650 02
- $a aktivace enzymů $7 D004789
- 650 02
- $a Escherichia coli $x genetika $7 D004926
- 650 02
- $a exony $7 D005091
- 650 02
- $a ženské pohlaví $7 D005260
- 650 12
- $a heterozygot $7 D006579
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kojenec $7 D007223
- 650 02
- $a novorozenec $7 D007231
- 650 02
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 02
- $a rodokmen $7 D010375
- 650 02
- $a fenotyp $7 D010641
- 650 02
- $a polymerázová řetězová reakce $7 D016133
- 650 02
- $a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
- 650 02
- $a restrikční mapování $7 D015183
- 650 02
- $a sekvenční analýza DNA $7 D017422
- 650 02
- $a sekvenční delece $7 D017384
- 650 02
- $a teplota $7 D013696
- 700 1_
- $a Bross, P.
- 700 1_
- $a Udvari, S.
- 700 1_
- $a Kirk, J.
- 700 1_
- $a Gray, G.
- 700 1_
- $a Kmoch, Stanislav, $d 1963- $7 xx0056529 $u Institute for Inherited Metabolic Diseases, General Faculty Hospital and Charles University 1st School of Medicine, Prague, Czech Republic
- 700 1_
- $a Chamoles, N.
- 700 1_
- $a Knudsen, I.
- 700 1_
- $a Winter, V.
- 700 1_
- $a Wilcken, B.
- 700 1_
- $a Yokota, I.
- 700 1_
- $a Hart, K.
- 700 1_
- $a Packman, S.
- 700 1_
- $a Harpey, J. P.
- 700 1_
- $a Saudubray, J. M.
- 700 1_
- $a Hale, D. E.
- 700 1_
- $a Bolund, L.
- 700 1_
- $a Kolvraa, S.
- 700 1_
- $a Gregersen, N.
- 773 0_
- $t Human Molecular Genetics $x 0964-6906 $g Roč. 6, č. 5 (1997), s. 695-707 $p Hum Mol Genet $w MED00002077
- 773 0_
- $p Hum Mol Genet $g 6(5):695-707, 1997 May $x 0964-6906
- 910 __
- $a ABA008 $b B 1813 $y z $z 0
- 990 __
- $a 20140124123326 $b ABA008
- 991 __
- $a 20140313155217 $b ABA008
- 999 __
- $a ok $b bmc $g 1008121 $s 841957
- BAS __
- $a 3
- BMC __
- $a 1997 $b 6 $c 5 $d 695-707 $i 0964-6906 $m Human molecular genetics $x MED00002077
- GRA __
- $a IZ3204 $p MZ0
- LZP __
- $a 2013-01/ewbo